Literature DB >> 22002230

Impact of implementing French antibiotic guidelines for acute respiratory-tract infections in a paediatric emergency department, 2005-2009.

F Angoulvant1, D Skurnik, H Bellanger, H Abdoul, X Bellettre, L Morin, M Aptecar, G Galli-Gibertini, O Bourdon, C Doit, A Faye, J-C Mercier, R Cohen, C Alberti.   

Abstract

Acute respiratory tract infections (ARTIs) are the main reason for antibiotic prescription in children. In 2005, the French Drug Agency published guidelines to minimise inappropriate use of antibiotics for ARTI. The purpose of this study was to assess the impact of implementing these guidelines in a paediatric emergency department. We retrospectively analysed data collected prospectively in a French paediatric emergency department from November 2005 (date of guideline implementation) to October 2009. For each child diagnosed with ARTI, we collected age, diagnosis, and prescribed antibiotics. We computed antibiotic prescription rates in the study population. During the study period, 53,055 children were diagnosed with ARTI and 59% of the 22,198 antibiotic prescriptions given at discharge were related to ARTI. The proportion of ARTI patients given antibiotic prescriptions fell from 32.1% during the first year to 21% in year 4 (p<10(-4), Cochran-Armitage test). Amoxicillin-clavulanic acid and amoxicillin accounted for 50% and 34% of antibiotic prescriptions for ARTI, respectively. French antibiotic guidelines led to significant decreases in antibiotic prescription for ARTI in our paediatric emergency department.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22002230     DOI: 10.1007/s10096-011-1442-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  34 in total

1.  Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features.

Authors:  A Courpon-Claudinon; A Lefort; X Panhard; O Clermont; Q Dornic; B Fantin; F Mentré; M Wolff; E Denamur; C Branger
Journal:  Clin Microbiol Infect       Date:  2011-04       Impact factor: 8.067

2.  Reducing antibiotic use in children: a randomized trial in 12 practices.

Authors:  J A Finkelstein; R L Davis; S F Dowell; J P Metlay; S B Soumerai; S L Rifas-Shiman; M Higham; Z Miller; I Miroshnik; A Pedan; R Platt
Journal:  Pediatrics       Date:  2001-07       Impact factor: 7.124

3.  European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005.

Authors:  A Muller; S Coenen; D L Monnet; H Goossens
Journal:  Euro Surveill       Date:  2007-10-11

Review 4.  Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe.

Authors:  T M Coque; F Baquero; R Canton
Journal:  Euro Surveill       Date:  2008-11-20

5.  Prescribers' indications for drugs in childhood: a survey of five European countries (Spain, France, Bulgaria, Slovakia and Russia).

Authors:  Emilio J Sanz; Miguel A Hernández; Svetla Ratchina; Leonid Stratchounsky; Maria Asuncion Peiré; Maryse Lapeyre Mestre; Bernard Horen; Milan Kriska; Halina Krajnakova; Hristina Momcheva; Daniela Encheva; Inocencia Martínez-Mir; Vicente Palop
Journal:  Acta Paediatr       Date:  2005-12       Impact factor: 2.299

6.  Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis.

Authors:  A C Nyquist; R Gonzales; J F Steiner; M A Sande
Journal:  JAMA       Date:  1998-03-18       Impact factor: 56.272

7.  Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994-2007.

Authors:  Matthew P Kronman; Adam L Hersh; Rui Feng; Yuan-Shung Huang; Grace E Lee; Samir S Shah
Journal:  Pediatrics       Date:  2011-02-14       Impact factor: 7.124

8.  Spectrum and frequency of illness presenting to a pediatric emergency department.

Authors:  M M Massin; J Montesanti; P Gérard; P Lepage
Journal:  Acta Clin Belg       Date:  2006 Jul-Aug       Impact factor: 1.264

9.  Selective decrease in consultations and antibiotic prescribing for acute respiratory tract infections in UK primary care up to 2006.

Authors:  Martin Gulliford; Radoslav Latinovic; Judith Charlton; Paul Little; Tjeerd van Staa; Mark Ashworth
Journal:  J Public Health (Oxf)       Date:  2009-09-04       Impact factor: 2.341

10.  Differences in antibiotic prescribing patterns for children younger than five years in the three major outpatient settings.

Authors:  Natasha B Halasa; Marie R Griffin; Yuwei Zhu; Kathryn M Edwards
Journal:  J Pediatr       Date:  2004-02       Impact factor: 4.406

View more
  10 in total

1.  Decreased Overall and Inappropriate Antibiotic Prescribing in a Veterans Affairs Hospital Emergency Department following a Peer Comparison-Based Stewardship Intervention.

Authors:  Deanna J Buehrle; Rameez H Phulpoto; Marilyn M Wagener; Cornelius J Clancy; Brooke K Decker
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

Review 2.  Selective testing strategies for diagnosing group A streptococcal infection in children with pharyngitis: a systematic review and prospective multicentre external validation study.

Authors:  Jérémie F Cohen; Robert Cohen; Corinne Levy; Franck Thollot; Mohamed Benani; Philippe Bidet; Martin Chalumeau
Journal:  CMAJ       Date:  2014-12-08       Impact factor: 8.262

Review 3.  A call to action for antimicrobial stewardship in the emergency department: approaches and strategies.

Authors:  Larissa May; Sara Cosgrove; Michelle L'Archeveque; David A Talan; Perry Payne; Jeanne Jordan; Richard E Rothman
Journal:  Ann Emerg Med       Date:  2012-11-02       Impact factor: 5.721

4.  Implementation strategies in emergency management of children: A scoping review.

Authors:  Alex Aregbesola; Ahmed M Abou-Setta; George N Okoli; Maya M Jeyaraman; Otto Lam; Viraj Kasireddy; Leslie Copstein; Nicole Askin; Kathryn M Sibley; Terry P Klassen
Journal:  PLoS One       Date:  2021-03-24       Impact factor: 3.240

Review 5.  Antibiotic stewardship programmes had a low impact on prescribing for acute respiratory tract infections in children.

Authors:  Matti Korppi
Journal:  Acta Paediatr       Date:  2022-05-08       Impact factor: 4.056

6.  Randomized controlled trial of parent therapeutic education on antibiotics to improve parent satisfaction and attitudes in a pediatric emergency department.

Authors:  François Angoulvant; Anne Rouault; Sonia Prot-Labarthe; Priscilla Boizeau; David Skurnik; Laurence Morin; Jean-Christophe Mercier; Corinne Alberti; Olivier Bourdon
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

7.  Antibiotic Usage Prior and During Hospitalization for Clinical Severe Pneumonia in Children under Five Years of Age in Rabat, Morocco.

Authors:  Imane Jroundi; Rachid Benmessaoud; Chafiq Mahraoui; Cinta Moraleda; Houssain Tligui; Myriam Seffar; Badr Sououd Benjelloun; Jordi Vila; Joaquim Ruiz; Pedro L Alonso; Quique Bassat
Journal:  Antibiotics (Basel)       Date:  2013-09-26

8.  Compliance with the current recommendations for prescribing antibiotics for paediatric community-acquired pneumonia is improving: data from a prospective study in a French network.

Authors:  Elise Launay; Karine Levieux; Corinne Levy; François Dubos; Alain Martinot; Bénédicte Vrignaud; Flora Lepage; Robert Cohen; Emmanuel Grimprel; Matthieu Hanf; François Angoulvant; Christèle Gras-Le Guen
Journal:  BMC Pediatr       Date:  2016-08-12       Impact factor: 2.125

9.  Antibiotic Use in Febrile Children Presenting to the Emergency Department: A Systematic Review.

Authors:  Elles M F van de Voort; Santiago Mintegi; Alain Gervaix; Henriette A Moll; Rianne Oostenbrink
Journal:  Front Pediatr       Date:  2018-10-08       Impact factor: 3.418

10.  Antibiotic prescription in the outpatient paediatric population attending emergency departments in Lombardy, Italy: a retrospective database review.

Authors:  Francesco Messina; Antonio Clavenna; Massimo Cartabia; Daniele Piovani; Angela Bortolotti; Ida Fortino; Luca Merlino; Maurizio Bonati
Journal:  BMJ Paediatr Open       Date:  2019-12-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.